VJHemOnc Podcast cover image

Highlights from iwMyeloma 2025: trial updates and practical considerations

VJHemOnc Podcast

00:00

Innovations in Myeloma Treatment

This chapter explores the advancements surrounding ABBV 383, a bi-specific therapy targeting BCMA, which offers new hope for myeloma patients through improved treatment schedules and reduced side effects. The discussion also covers future treatments, such as gamma secretase inhibitors, and the importance of personalized approaches in enhancing treatment efficacy.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app